Dendritic Cell Vaccination in Melanoma Patients Scheduled for Regional Lymph Node Dissection
NCT00243594
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
COMPLETED
Status
40
Enrollment
OTHER
Sponsor class
Conditions
Melanoma Stage III or IV
Interventions
BIOLOGICAL:
Peptide-pulsed dendritic cells
Sponsor
Radboud University Medical Center
Collaborators
[object Object]